Pro-Dex Inc (PDEX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $210.11M
Last updated: Nov 17, 2026 at 11:06 AM ET
Pro-Dex Inc (PDEX) Financials: Revenue, Profit and Cash Flow
Pro-Dex reported revenue of $77.55M for the fiscal year ended Jun 30, 2026, up 16.5% from the year before. That year, net income was $13.66M with a net margin of 17.6%, operating cash flow was $7.24M and free cash flow was $6.76M. The quarter ended Jun 30, 2026 had revenue of $20.41M and net income of $2.86M.
Revenue and Margins
The operating margin was 16.8% in the fiscal year ended Jun 2026. Over the 9 years to Jun 2026, revenue grew from $21.94M, a compound annual rate of 15.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $77.55M | +16.5% | 31.4% | 16.8% | 17.6% |
| Jun 2025 | $66.59M | +23.7% | 29.3% | 16.1% | 13.5% |
| Jun 2024 | $53.84M | +16.8% | 27.0% | 13.3% | 4.0% |
| Jun 2023 | $46.09M | +9.6% | 27.7% | 12.5% | 15.3% |
| Jun 2022 | $42.04M | +10.5% | 31.2% | 12.2% | 10.9% |
| Jun 2021 | $38.03M | +9.2% | 35.7% | 11.9% | 16.2% |
| Jun 2020 | $34.83M | +28.2% | 37.7% | 20.3% | 17.5% |
| Jun 2019 | $27.17M | +21.0% | 36.0% | 18.4% | 15.3% |
| Jun 2018 | $22.46M | +2.4% | 35.4% | 10.6% | 7.2% |
| Jun 2017 | $21.94M | N/A | 32.7% | 12.5% | 23.2% |
Income Statement
In the fiscal year ended Jun 2026, net income rose 52.1% from the year before. In the quarter ended Jun 2026, net income rose 138.3% from the same quarter a year earlier.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77.55M | $66.59M | $53.84M | $46.09M | $42.04M | $38.03M | $34.83M | $27.17M | $22.46M | $21.94M |
| Cost of revenue | $53.21M | $47.08M | $39.29M | $33.34M | $28.91M | $24.45M | $21.69M | $17.39M | $14.52M | $14.76M |
| Gross profit | $24.34M | $19.51M | $14.55M | $12.75M | $13.13M | $13.57M | $13.14M | $9.78M | $7.94M | $7.19M |
| Research and development | $3.35M | $3.64M | $3.19M | $2.80M | $2.98M | $4.38M | $2.31M | $1.88M | $1.89M | $1.23M |
| Operating income | $12.99M | $10.69M | $7.17M | $5.76M | $5.12M | $4.53M | $7.07M | $5.00M | $2.39M | $2.74M |
| Net income | $13.66M | $8.98M | $2.13M | $7.07M | $4.57M | $6.17M | $6.11M | $4.15M | $1.62M | $5.08M |
| EBITDA | $14.35M | $11.90M | N/A | $10.54M | $6.78M | $7.20M | $8.60M | $5.49M | $2.95M | $3.29M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.41M | $19.95M | $18.66M | $18.53M | $17.49M | $17.41M | $16.79M | $14.89M | $15.03M | $14.29M | $12.59M | $11.94M |
| Gross profit | $7.09M | $6.13M | $5.74M | $5.37M | $3.49M | $5.80M | $5.07M | $5.15M | $4.09M | $4.00M | $2.80M | $3.66M |
| Operating income | $3.53M | $3.09M | $3.26M | $3.11M | $1.34M | $3.64M | $2.69M | $3.01M | $2.35M | $2.21M | $777.00K | $1.83M |
| Net income | $2.86M | $3.94M | $2.19M | $4.68M | $1.20M | $3.27M | $2.04M | $2.47M | $1.59M | $655.00K | $500.00K | -$615.00K |
Balance Sheet
As of Jun 2026, total debt of $17.47M exceeded cash and equivalents by $9.28M.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $74.51M | $61.19M | $52.48M | $51.82M | $49.09M | $40.32M | $31.13M | $25.52M | $19.92M | $16.35M |
| Current assets | $53.25M | $47.30M | $36.61M | $30.98M | $31.17M | $25.01M | $22.67M | $20.84M | $16.23M | $12.28M |
| Cash and equivalents | $8.19M | $419.00K | $2.63M | $2.94M | $849.00K | $3.72M | $6.42M | $7.74M | $5.19M | $4.21M |
| Total liabilities | $26.88M | $24.56M | $21.61M | $20.23M | $23.66M | $20.24M | $12.06M | $8.51M | $2.64M | $2.64M |
| Short-term debt | $4.21M | $6.15M | $4.37M | $3.83M | $3.29M | $1.24M | $651.00K | $622.00K | $35.00K | $58.00K |
| Long-term debt | $13.27M | $9.25M | $7.54M | $8.91M | $10.25M | $11.54M | $3.28M | $3.93M | $6.00K | $61.00K |
| Shareholder equity | $47.63M | $36.63M | $30.87M | $31.59M | $25.43M | $20.08M | $19.06M | $17.01M | $17.28M | $13.71M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $74.51M | $74.98M | $62.26M | $64.30M | $61.19M | $64.27M | $60.37M | $54.31M | $54.21M | $50.55M | $51.43M | $49.59M |
| Total liabilities | $26.88M | $29.78M | $20.63M | $22.79M | $24.56M | $28.99M | $28.55M | $23.43M | $23.34M | $19.61M | $19.64M | $18.39M |
| Cash and equivalents | $8.19M | $9.99M | $7.95M | $514.00K | $419.00K | $4.47M | $66.00K | $3.08M | $2.63M | $3.22M | $1.29M | $1.90M |
| Shareholder equity | $47.63M | $45.20M | $41.63M | $41.51M | $36.63M | $35.28M | $31.82M | $30.88M | $30.87M | $30.94M | $31.79M | $31.20M |
Cash Flow
In the fiscal year ended Jun 2026, free cash flow was 93.4% of operating cash flow. Share repurchases came to 50.4% of it.
Annual
| Line item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.24M | -$1.68M | $6.22M | $5.46M | -$847.00K | -$2.08M | $4.95M | $3.33M | $3.10M | $3.23M |
| Capital expenditures | $483.00K | $1.25M | $983.00K | $974.00K | $0 | $6.50M | $519.00K | $1.39M | $923.00K | $606.00K |
| Free cash flow | $6.76M | -$2.93M | $5.24M | $4.49M | -$847.00K | -$8.58M | $4.43M | $1.94M | $2.17M | $2.63M |
| Dividends paid | N/A | N/A | N/A | $89.00K | N/A | $259.00K | $15.00K | $23.00K | $0 | $0 |
| Share repurchases | $3.41M | $3.50M | $3.50M | $1.55M | $1.61M | $5.54M | $3.39M | $3.98M | $220.00K | $312.00K |
| Investing cash flow | $3.91M | -$238.00K | -$2.23M | -$885.00K | -$1.24M | -$3.71M | -$2.29M | -$1.22M | -$4.12M | -$1.03M |
| Financing cash flow | -$3.38M | -$292.00K | -$4.30M | -$2.49M | -$790.00K | $3.09M | -$3.98M | $450.00K | $2.00M | -$298.00K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$273.00K | $1.63M | $3.57M | $2.31M | -$173.00K | $754.00K | -$4.15M | $1.89M | $1.04M | $4.08M | $710.00K | $392.00K |
| Capital expenditures | $203.00K | $112.00K | $70.00K | $98.00K | $93.00K | $180.00K | $542.00K | $431.00K | $107.00K | $117.00K | $633.00K | $126.00K |
| Free cash flow | -$476.00K | $1.52M | $3.50M | $2.21M | -$266.00K | $574.00K | -$4.69M | $1.46M | $938.00K | $3.96M | $77.00K | $266.00K |
Frequently Asked Questions About PDEX
What is Pro-Dex's annual revenue?
Pro-Dex reported revenue of $77.55M for the fiscal year ended Jun 30, 2026.
How fast is Pro-Dex's revenue growing?
Revenue was up 16.5% for the fiscal year ended Jun 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 18.9%.
Is Pro-Dex profitable?
Yes. Pro-Dex reported net income of $13.66M for the fiscal year ended Jun 30, 2026, with a net margin of 17.6%.
How much free cash flow does PDEX generate?
For the fiscal year ended Jun 30, 2026, operating cash flow of $7.24M minus capital expenditures of $483.00K produced free cash flow of $6.76M.
How much debt does Pro-Dex have?
The balance sheet dated Jun 30, 2026 reported long-term debt of $13.27M, short-term debt of $4.21M and cash and equivalents of $8.19M.
PDEX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors